TMO
2025Q4BMOThermo Fisher Scientific Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH
Street
Consensus EPS6.45
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move1.6%
IV front—
P/C full—
P/C front—
Features as of2026-01-28
Run-up
Close—
Ret 5d-4.4%
Ret 10d+0.2%
Ret 20d+3.9%
Ret 30d+6.2%
Actual EPS
6.57Beat
Estimated EPS6.45
Actual revenue
12.2B
Surprise %+1.9%
Beat / missBeat
Beat streak 44
Beat streak 88
Reaction
1-day stock reaction+1.1%
Implied vs actual
Implied 1.6%Actual 3.7%
Gap reaction-3.7%
Day result-2.6%
Next-day upYes
Realized / IV2.34×
Post tape
Post 5d-8.4%
Post 10d-13.9%
Post volume4.0M
Vol ×10d1.56×
Vol ×20d1.66×
Post range4.1%